Clinical Trials
6 trialsNCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT03090880 2022-11-17
PROVE
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT02583191 2021-05-03
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
AIO-Studien-gGmbH
Phase 3 Terminated
NCT00876915 2015-11-24
PHACS
University of Rochester
Phase 3 Terminated
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated